Patents by Inventor Anthony Nastase

Anthony Nastase has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10519114
    Abstract: Disclosed herein are compounds useful for modulating the mu-opioid receptor (“MOR”) and/or delta-opioid receptor (“DOR”), and methods of using these compounds to treat diseases and conditions, such as pain. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: December 31, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Henry Mosberg, Deanna Montgomery, Aaron Bender, Anthony Nastase, Sean Henry, Aubrie Harland
  • Publication number: 20180072677
    Abstract: Disclosed herein are compounds useful for modulating the mu-opioid receptor (“MOR”) and/or delta-opioid receptor (“DOR”), and methods of using these compounds to treat diseases and conditions, such as pain. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    Type: Application
    Filed: September 15, 2017
    Publication date: March 15, 2018
    Inventors: Henry Mosberg, Deanna Montgomery, Aaron Bender, Anthony Nastase, Sean Henry, Aubrie Harland